Skip to main content
Careers Contact us

News

Press release year list 2020 2019 2018 2017 2016 2015 2014
10/01/2020
Exicure Secures Debt Facility for Up to $25.0 Million
09/16/2020
Exicure Presents Promising Interim Results from Ongoing Phase 1b/2 Trial of Cavrotolimod at Virtual KOL Event Today
09/10/2020
Exicure to Present at Upcoming Conferences
08/25/2020
Exicure Announces a Virtual KOL Meeting to Discuss Preliminary Phase 1b Efficacy Data for Cavrotolimod
08/12/2020
Exicure, Inc. Reports Second Quarter 2020 Financial Results and Corporate Progress
08/05/2020
Exicure, Inc. to Present at the BTIG Virtual Biotechnology Conference 2020
06/29/2020
Exicure, Inc. Added to Russell 2000® Index
06/22/2020
Exicure Presents Cavrotolimod (AST-008) Clinical Data at AACR 2020 Virtual Meeting
06/18/2020
Exicure, Inc. to Present at the 2020 BMO Prescription for Success Healthcare Conference
06/16/2020
Exicure Announces First Patient Dosed in Phase 2 Merkel Cell Carcinoma Trial of Cavrotolimod (AST-008)
05/20/2020
Exicure, Inc. to Present at Jefferies 2020 Healthcare Conference
05/19/2020
Exicure Announces Appointment of Dr. Douglas E. Feltner as Chief Medical Officer
05/15/2020
Exicure to Present Clinical Data at AACR 2020 Virtual Meeting
05/14/2020
Exicure to Present at the American Society of Clinical Oncology 2020
05/14/2020
Exicure, Inc. Reports First Quarter 2020 Financial Results and Corporate Progress
05/05/2020
Exicure to Present AST-008 Updates at 2020 AACR Virtual Annual Meeting
04/07/2020
Exicure, Inc. Announces Appointment of Timothy P. Walbert as Chairman of the Board
Download PDF format download (opens in new window)
03/30/2020
Exicure Provides Business Update Amid COVID-19 Pandemic
Download PDF format download (opens in new window)
03/03/2020
Exicure, Inc. Reports Full Year 2019 Financial Results and Corporate Progress
Download PDF format download (opens in new window)
03/02/2020
Exicure to Present at the Cowen 40th Annual Healthcare Conference
Download PDF format download (opens in new window)